Co-targeting the EGFR and IGF-IR with anti-EGFR monoclonal antibody ICR62 and the IGF-IR tyrosine kinase inhibitor NVP-AEW541 in colorectal cancer cells. - Cunningham MP; Thomas H; Marks C; Green M; Fan Z; Modjtahedi H (International journal of oncology, 2008)